AntlerA Therapeutics
AntlerA Therapies is a regenerative medicine startup that is working on protein therapeutics that modulate developmental signaling pathways while also mobilizing tissue stem cell activity to enable endogenous tissue repair. They generated powerful antibody-like molecules (ANTs) that activate certain Frizzed receptor complexes using their unique protein engineering platform.
Industries
biotechnology
medical
therapeutics
Nr. of Employees
small (1-50)
AntlerA Therapeutics
Products
Norrin/Wnt-agonist ANT antibody
A clinical antibody molecule developed for the treatment of retinopathies, focusing on restoring blood vessels integrity in the eye.
ANTs for regenerative medicine
Precision-engineered antibody therapeutics developed using a programmable ANT platform, aimed at treating retinopathies by maintaining blood vessel integrity.
Norrin/Wnt-agonist ANT antibody
A clinical antibody molecule developed for the treatment of retinopathies, focusing on restoring blood vessels integrity in the eye.
ANTs for regenerative medicine
Precision-engineered antibody therapeutics developed using a programmable ANT platform, aimed at treating retinopathies by maintaining blood vessel integrity.